申请人:BioDiem, Ltd
公开号:US20150258059A1
公开(公告)日:2015-09-17
The present invention relates to a method of treatment and/or prophylaxis of a microbial infection, comprising the step of administering an effective amount of a compound of formula (I), in which X and Y are either the same or different and selected from a heteroatom; is a double or single bond depending on the heteroatoms X and Y; R
1
to R
5
are either the same or different and selected from hydrogen or a non-deleterious substituent; and R
6
and R
7
are either the same or different and selected from hydrogen and a non-deleterious substituent or one of R
6
and R
7
are absent when there is a double bond present, pharmaceutically acceptable salts or derivatives, pro-drugs, tautomers and/or isomers thereof. The present invention also relates to a method for protecting a subject from radiation damage, a method of cancer radiotherapy and use as an antimicrobial or radioprotective agent of the compound of formula (I) defined above. Some of the compounds of formula (I) are novel and are also described in the present invention, together with pharmaceutical or veterinary compositions containing them.
本发明涉及一种治疗和/或预防微生物感染的方法,包括给予化合物(I)的有效量,其中X和Y可以相同也可以不同,并且选自杂原子;根据杂原子X和Y,是双键或单键;R1至R5可以相同也可以不同,并且选自氢或非有害取代基;R6和R7可以相同也可以不同,并且选自氢和非有害取代基,或者当存在双键时,R6和R7中的一个可以缺失;药学上可接受的盐或衍生物,前药,互变异构体和/或同分异构体。本发明还涉及一种保护受试者免受辐射损伤的方法,一种癌症放射治疗方法以及将上述化合物(I)用作抗微生物或放射防护剂的用途。化合物(I)的一些是新颖的,在本发明中也有描述,以及含有它们的药用或兽用组合物。